| Q50893125 | 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. |
| Q58762162 | 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures |
| Q51002019 | A novel nonsense NBEAL2 gene mutation causing severe bleeding in a patient with gray platelet syndrome. |
| Q24624821 | A unique region of RILP distinguishes it from its related proteins in its regulation of lysosomal morphology and interaction with Rab7 and Rab34 |
| Q34562161 | Absence of platelet phenotype in mice lacking the motor protein myosin Va |
| Q62977574 | Activated human platelet products induce proarrhythmic effects in ventricular myocytes |
| Q37786647 | Activated platelets and atherosclerosis |
| Q92187415 | After-Death Functions of Cell Death |
| Q57158274 | Alterations in platelet secretion differentially affect thrombosis and hemostasis |
| Q33379078 | Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection |
| Q43235803 | An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia. |
| Q41113308 | Anti-CXCL4 monoclonal antibody accelerates telogen to anagen transition and attenuates apoptosis of the hair follicle in mice |
| Q44528734 | Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans |
| Q98771792 | Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets |
| Q26750898 | Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation? |
| Q35608778 | Aspirin: pharmacology and clinical applications |
| Q24297788 | BLOC-1, a novel complex containing the pallidin and muted proteins involved in the biogenesis of melanosomes and platelet-dense granules |
| Q24315003 | BLOC-2, AP-3, and AP-1 proteins function in concert with Rab38 and Rab32 proteins to mediate protein trafficking to lysosome-related organelles |
| Q53581386 | Bcl-2 family proteins are essential for platelet survival. |
| Q33394357 | Beyond thrombosis: the versatile platelet in critical illness |
| Q47096645 | Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? |
| Q38063806 | Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. |
| Q35768173 | Canine Platelet Lysate Is Inferior to Fetal Bovine Serum for the Isolation and Propagation of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells |
| Q33399680 | Cells in dengue virus infection in vivo. |
| Q38314202 | Chronic hepatitis B: role of anti-platelet therapy in inflammation control |
| Q92533083 | Combined deficiency of RAB32 and RAB38 in the mouse mimics Hermansky-Pudlak syndrome and critically impairs thrombosis |
| Q97526989 | Comparative Platelet Releasate Proteomic Profiling of Acute Coronary Syndrome versus Stable Coronary Artery Disease |
| Q34608011 | Complementary effects of extracellular nucleotides and platelet-derived extracts on angiogenesis of vasa vasorum endothelial cells in vitro and subcutaneous Matrigel plugs in vivo |
| Q42687813 | Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate |
| Q41836288 | Cytoskeleton dynamics in drug-treated platelets |
| Q35153219 | Defective release of α granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models |
| Q40384839 | Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency |
| Q50863295 | Detection of Lysosomal Exocytosis in Platelets by Flow Cytometry. |
| Q34874784 | Development of platelet secretory granules |
| Q37187795 | Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics |
| Q64986176 | Early Blood Biomarkers to Improve Sepsis/Bacteremia Diagnostics in Pediatric Emergency Settings. |
| Q43109023 | Effects of Platelet-Rich Plasma Composition on Anabolic and Catabolic Activities in Equine Cartilage and Meniscal Explants |
| Q45050007 | Effects of platelet lysates on select bone cell functions |
| Q27016553 | Emerging roles for platelets as immune and inflammatory cells |
| Q33435199 | Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo |
| Q55417580 | Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography. |
| Q44288535 | Equine platelet CD62P (P-selectin) expression: a phenotypic and morphologic study. |
| Q36393452 | Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system. |
| Q37096976 | Ex vivo apoptotic and autophagic influence of an estradiol analogue on platelets. |
| Q39401811 | Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment |
| Q52680357 | From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. |
| Q47396992 | Germline heterozygous variants in genes associated with familial hemophagocytic lymphohistiocytosis as a cause of increased bleeding |
| Q24618306 | Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p |
| Q35185593 | Historical perspective and future directions in platelet research |
| Q33393804 | Homozygosity mapping with SNP arrays confirms 3p21 as a recessive locus for gray platelet syndrome and narrows the interval significantly |
| Q57027381 | Human blood platelets and viruses: defense mechanism and role in the removal of viral pathogens |
| Q46528085 | Human platelet lysate supplementation of mesenchymal stromal cell delivery: issues of xenogenicity and species variability |
| Q93014312 | Hypothermia-induced activation of the splenic platelet pool as a risk factor for thrombotic disease in a mouse model |
| Q90342671 | Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps |
| Q27692706 | Inflammasome in platelets: allying coagulation and inflammation in infectious and sterile diseases? |
| Q37195332 | Influence of mental stress on platelet bioactivity |
| Q26778920 | Interaction between circulating cancer cells and platelets: clinical implication |
| Q93379460 | Interaction between platelets and endothelium: from pathophysiology to new therapeutic options |
| Q50968298 | Lack of inhibitory effect of acetylsalicylic acid and meloxicam on whole blood platelet aggregation in cats. |
| Q38944642 | Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. |
| Q42133744 | Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice |
| Q43172723 | Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions |
| Q58701086 | Megakaryocyte Contribution to Bone Marrow Fibrosis: many Arrows in the Quiver |
| Q39100850 | Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging |
| Q36209119 | Molecular aspects of thrombosis and antithrombotic drugs |
| Q24314992 | NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules |
| Q52325694 | No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury. |
| Q39144118 | Normal platelet function in platelet concentrates requires non-platelet cells: a comparative in vitro evaluation of leucocyte-rich (type 1a) and leucocyte-poor (type 3b) platelet concentrates |
| Q92967388 | Nucleotide Sugar Transporter SLC35 Family Structure and Function |
| Q39421886 | Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters |
| Q47138311 | Optimized plasma preparation is essential to monitor platelet-stored molecules in humans |
| Q46763598 | Oxidative stress in blood platelets from schizophrenic patients. |
| Q54389473 | PDK1 selectively phosphorylates Thr(308) on Akt and contributes to human platelet functional responses. |
| Q42064117 | Pairwise agonist scanning-flow cytometry (PAS-FC) measures inside-out signaling and patient-specific response to combinatorial platelet agonists |
| Q51337005 | Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. |
| Q95595984 | Platelet Function and Therapeutic Applications in Dogs: Current Status and Future Prospects |
| Q40190199 | Platelet P-selectin is significantly involved in leukocyte-endothelial cell interaction in murine antigen-induced arthritis |
| Q37235603 | Platelet activation, and antiplatelet targets and agents: current and novel strategies. |
| Q42796609 | Platelet aggregation pathway |
| Q34609301 | Platelet alpha granules in BLOC-2 and BLOC-3 subtypes of Hermansky-Pudlak syndrome |
| Q37487079 | Platelet alpha-granules: basic biology and clinical correlates |
| Q38073155 | Platelet biology and receptor pathways. |
| Q88177943 | Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research |
| Q28186087 | Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense |
| Q38666764 | Platelet concentrates for bone regeneration: Current evidence and future challenges. |
| Q37591554 | Platelet dysfunction and stroke in the female migraineur |
| Q38165928 | Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures |
| Q28546748 | Platelet mechanosensing of collagen matrices |
| Q37982455 | Platelet signaling-a primer. |
| Q36203094 | Platelet studies in autism spectrum disorder patients and first-degree relatives |
| Q34182418 | Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury |
| Q38543281 | Platelet-delivered therapeutics |
| Q26801024 | Platelet-rich Plasma as a Potential Treatment for Noncicatricial Alopecias |
| Q35829738 | Platelet-rich plasma peptides: key for regeneration |
| Q45307946 | Plateletpheresis does not cause long-standing platelet-derived growth factor release into the donor blood. |
| Q38542454 | Platelets and Their Interactions with Other Immune Cells |
| Q38691783 | Platelets and cancer angiogenesis nexus. |
| Q37855541 | Platelets and cardiac arrhythmia |
| Q33369958 | Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage |
| Q35097332 | Platelets and smooth muscle cells affecting the differentiation of monocytes |
| Q64274965 | Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target |
| Q89624089 | Platelets in chronic liver disease, from bench to bedside |
| Q38364980 | Platelets in leucocyte recruitment and function |
| Q33437331 | Platelets in liver and renal disease |
| Q28080840 | Platelets in patients with aspirin-exacerbated respiratory disease |
| Q53188141 | Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion. |
| Q38038674 | Platelets, complement and tissue inflammation |
| Q47178294 | Platelets: an outlook from biology through evidence-based achievements in critical care |
| Q38099418 | Platelets: bridging hemostasis, inflammation, and immunity |
| Q36818465 | Prevention of abdominal adhesions--present state and what's beyond the horizon? |
| Q64245719 | Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis |
| Q37595481 | Pro-coagulant activity during exercise testing in patients with coronary artery disease. |
| Q98290659 | Proposal of a New Standardized Freeze-Thawing Technical Protocol for Leucocyte-Poor Platelet-Rich Plasma Preparation and Cryopreservation |
| Q53262195 | Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets. |
| Q47890629 | Protein levels of clusterin and glutathione synthetase in platelets allow for early detection of colorectal cancer. |
| Q33223828 | Pseudo-storage pool disease due to platelet degranulation in EDTA-collected peripheral blood: a rare artifact |
| Q92069669 | Quantal Basis of Secretory Granule Biogenesis and Inventory Maintenance: the Surreptitious Nano-machine Behind It |
| Q41915093 | Regenerative medicine in aesthetic surgery: hope or hype? |
| Q42155668 | Role of Munc13-4 as a Ca2+-dependent tether during platelet secretion |
| Q59791517 | Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation |
| Q41116679 | Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation |
| Q54619325 | Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation. |
| Q90733622 | Smoking cessation affects human platelet activation induced by collagen |
| Q46863524 | Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner |
| Q26799282 | Stem cell autotomy and niche interaction in different systems |
| Q35902865 | Super-resolution microscopy as a potential approach to diagnosis of platelet granule disorders. |
| Q59146803 | The Effect of PEI and PVP-Stabilized Gold Nanoparticles on Equine Platelets Activation: Potential Application in Equine Regenerative Medicine |
| Q91909732 | The Effectiveness of Autologous Platelet Rich Plasma Application in the Wound Bed Prior to Resurfacing with Split Thickness Skin Graft vs. Conventional Mechanical Fixation Using Sutures and Staples |
| Q38967828 | The Safety and Efficacy of Cell-Assisted Fat Grafting to Traditional Fat Grafting in the Anterior Mid-Face: An Indirect Assessment by 3D Imaging |
| Q35628934 | The Slc35d3 gene, encoding an orphan nucleotide sugar transporter, regulates platelet-dense granules |
| Q45975069 | The changes of aggregability of blood platelets in schizophrenia. |
| Q39161005 | The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets |
| Q43197783 | The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets |
| Q47101587 | The effects of platelet lysate on maturation, fertilization and embryo development of NMRI mouse oocytes at germinal vesicle stage. |
| Q35206747 | The evolving role of platelets in inflammation. |
| Q38156780 | The platelet fibrinogen receptor: from megakaryocyte to the mortuary |
| Q37242670 | The role of platelet activation in tumor metastasis. |
| Q34335768 | The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury |
| Q30437474 | The role of platelets in acute lung injury (ALI) |
| Q26863134 | The signaling role of CD40 ligand in platelet biology and in platelet component transfusion |
| Q42518733 | Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiol-containing proteins. |
| Q28246124 | Thrombin and vascular inflammation |
| Q57029279 | Thrombocytopenia is associated with severe retinopathy of prematurity |
| Q38725992 | Transfusion-related acute lung injury: transfusion, platelets and biological response modifiers |
| Q50048913 | Use of Platelet-Rich Plasma Immediately After an Injury Did Not Improve Ligament Healing, and Increasing Platelet Concentrations Was Detrimental in an In Vivo Animal Model. |
| Q90599463 | Use of intraarticular injections of platelet-rich plasma in the treatment of knee osteoarthritis: A review article |
| Q33575884 | Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors |
| Q45950688 | alphaB-crystallin extracellularly suppresses ADP-induced granule secretion from human platelets. |